Episode Details

Amgen is recalling nearly one million bottles of heart and kidney meds—Corlanor and Sensipar—after discovering foreign matter on tablet coatings, all from a specific packaging site. The FDA rates it a low-risk Class Two recall, meaning temporary issues are possible but serious harm is unlikely. These drugs, used for chronic heart failure and kidney-related parathyroid disorders, were shipped between late 2021 and late 2022. Patients should check if their prescription is affected—this recall covers multiple strengths and bottle sizes. Amgen’s move is precautionary, prioritizing safety despite the unsettling find.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/209d46f0439c684a